alexa Is Oral Ibuprofen Better than Intravenous Indomethacin
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Is Oral Ibuprofen Better than Intravenous Indomethacin for Medical Closure of the Patent Ductus Arteriosus in Preterm Infants?

Abdulmajid Mustafa Almawazini*, Abdulmajid Mustafa Almawazini, Ali Said Dammas Al-Ghamdi, Hamdi Hanafi Katar, Ali A Al Sharkawy, Ahmed Hussein Iqelan and Yunis Abdalla Yunis

Department of Pediatrics and Neonatology, King Fahad Hospital Albaha, Saudi Arabia

*Corresponding Author:
Abdulmajid Mustafa Almawazini
Consultant, Pediatric Cardiologist
Department of Pediatrics and Neonatology
King Fahad Hospital Albaha
P.O Box 204, Albaha 65411, Saudi Arabia
Tel: 00966508294471
E-mail: [email protected]

Received Date: December 29, 2014, Accepted January 26, 2015, Published January 28, 2015

Citation: Almawazini AM, Almawazini AM, Al-Ghamdi ASD, Katar HH, Sharkawy AAA, et al. (2015) Is Oral Ibuprofen Better than Intravenous Indomethacin for Medical Closure of the Patent Ductus Arteriosus in Preterm Infants?. Pediat Therapeut 5:231. doi:10.4172/2161-0665.1000231

Copyright: © 2015 Almawazini AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Patent Ductus Arteriosus is an open channel between the aorta and pulmonary artery. The

incidence of patent ductus arteriosus (PDA) is approximately 40% in premature infants. Objectives and Methods: To determine the effectiveness and safety of ibuprofen compared to intravenous indomethacin for closing a PDA in preterm and/or low birth weight infants. This is a case control study, retrospective review of the files of infants in control group given intravenous indomethacin, as conventional treatment: first dose of 2 mg/kg, then two doses of 0.1 mg/kg after 12 hr, 36hr respectively if the infant is either <7 days old or <1250 g, and three doses of 0.2 mg/kg if patients >7 days old or >1250 g. Infants who received oral ibuprofen in case group, as a new treatment (10 mg/kg initially followed by two doses of 5 mg/kg by interval of 24 hours) for symptomatic PDA in a neonatal intensive care unit in Pediatric and Neonatology Department, King Fahad Hospital Albaha, from January 2007 till December 2013. Only patients with isolated PDA included, while PDA associated with other congenital heart disease was excluded. Results: A total of 104 infants as control (group 1) received IV indomethacin, and 104 pts as a case (group 2) received oral ibuprofen. Among the survivors, the closure rate was 89.4% (93/104) in the indomethacin group and 91.3% (95/104) in the ibuprofen group (p =0.443). Significantly the incidence of complications was lower in the ibuprofen group: elevated serum creatinine (14.4% versus7.7%), oliguria (19.2 % versus 9.6%), and upper gastrointestinal hemorrhage (11.5 versus 4.8%); respectively (p: 0.034, p: 0.038, and p: 0.048). The incidence of necrotizing enterocolitis was higher in the indomethacin group (5.8% versus 3.9%) but not significant (p: 0.233). Conclusion: oral ibuprofen is as effective as intravenous indomethacin for closure of PDA and is associated with significantly less complications.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords